NASDAQ · BIOX
Basic Materials · Agricultural Inputs
$0.23
Down-$0.02 (-7.76%)
Updated Oct 30, 2026, 8:53 AM
SID Score
2.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · BIOX
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 29, 2026
BIOX closed at $0.23 after 21 trading sessions, down 34.30% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 29, 2026 | $0.242 | $0.25 | $0.2105 | $0.2295 | 209.16K |
| Oct 28, 2026 | $0.23 | $0.255 | $0.2013 | $0.2488 | 379.3K |
| Oct 27, 2026 | $0.21 | $0.2391 | $0.2031 | $0.2374 | 246.77K |
| Oct 26, 2026 | $0.2276 | $0.2391 | $0.2014 | $0.203 | 392.29K |
| Oct 23, 2026 | $0.26 | $0.2716 | $0.19 | $0.2346 | 549.14K |
| Oct 22, 2026 | $0.242 | $0.2743 | $0.242 | $0.255 | 151.19K |
| Oct 21, 2026 | $0.259 | $0.26 | $0.2337 | $0.2449 | 179.41K |
| Oct 20, 2026 | $0.26 | $0.26 | $0.2401 | $0.2518 | 233.46K |
| Oct 19, 2026 | $0.287 | $0.287 | $0.2526 | $0.2551 | 263.28K |
| Oct 16, 2026 | $0.29 | $0.306 | $0.2607 | $0.2756 | 333.95K |
| Oct 15, 2026 | $0.3001 | $0.3224 | $0.28 | $0.294 | 251.23K |
| Oct 14, 2026 | $0.3251 | $0.3332 | $0.3001 | $0.3001 | 240.01K |
| Oct 13, 2026 | $0.3304 | $0.3347 | $0.3213 | $0.325 | 31.19K |
| Oct 12, 2026 | $0.33 | $0.3347 | $0.32 | $0.331 | 111.14K |
| Oct 9, 2026 | $0.3271 | $0.335 | $0.32 | $0.3283 | 127.76K |
| Oct 8, 2026 | $0.321 | $0.337 | $0.321 | $0.3282 | 55.14K |
| Oct 7, 2026 | $0.34 | $0.3455 | $0.3232 | $0.3345 | 132.38K |
| Oct 6, 2026 | $0.3266 | $0.3506 | $0.3266 | $0.3403 | 93.09K |
| Oct 5, 2026 | $0.3397 | $0.3558 | $0.315 | $0.3457 | 288.4K |
| Oct 2, 2026 | $0.344 | $0.3599 | $0.3402 | $0.3418 | 73.39K |
| Oct 1, 2026 | $0.35 | $0.3575 | $0.3473 | $0.3493 | 35.2K |
The latest Smart Investors Daily articles mentioning BIOX.
Company
Market Activity
Research & News
BIOX research
Company profile and research snapshot.
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jan 2, 2026 | Canaccord Genuity | Hold | — |
| Nov 14, 2025 | Canaccord Genuity | Hold | — |
| Sep 10, 2025 | Lake Street | Buy | — |
| Sep 10, 2025 | Canaccord Genuity | Hold | — |
| Jul 15, 2025 | Oppenheimer | Outperform | — |
No generated briefing is available yet.
Yahoo · Oct 28, 2026
Investing.com -- Deutsche Bank upgraded French diagnostics company bioMérieux to "buy" from "hold" and raised its price target to €103 from €75, saying an earlier start to the U.S. flu season has reduced the risk to the company’s 2026 guidance.
Yahoo · Sep 15, 2026
Bioceres Crop Solutions Corp (BIOX) posted flat Q4 revenue of $55.9 million and positive adjusted EBITDA, but full-year sales fell 18% amid litigation and a leveraged balance sheet.
Yahoo · Sep 15, 2026
CEO reports stabilized Argentina operations and $20M cost cuts amid 18% revenue decline.
Yahoo · Sep 15, 2026
Moby summary of Bioceres Crop Solutions Corp.'s Q4 2026 earnings call
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning BIOX.
